Additional information regarding falsified lamivudine, zidovudine and nevirapine tablets (Zidolam - N) in Kenya
M
Points to consider for inspections of biowaiver data
M
The WHO Prequalification of Medicines Programme (PQP) intends to include in its inspection programme, sites that have performed comparative dissolution studies submitted in prod
Notice of concern (NOC) withdrawn for Bombay Bioresearch Center (BBRC), India
M
Following corrective actions taken by Bombay Bioresearch Center (BBRC) and the clarifications provided being considered acceptable, and considering the outcome of an additional inspe